{"count": 2, "results": [{"_id": "17561641", "pmid": 17561641, "title": "[Alternative approaches to treatment of paroxysmal atrial fibrillation].", "journal": "Vestn Ross Akad Med Nauk", "authors": ["Tatarskiĭ BA"], "date": "2007-01-01T00:00:00Z", "meta_date_publication": "2007", "meta_volume": "", "meta_issue": "4", "meta_pages": "3-9", "score": 50035.645, "text_hl": "The results show that \"tablets in the pocket\" strategy is the most effective and safe method of treatment of rare episodes of @DISEASE_Atrial_Fibrillation @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ in @SPECIES_9606 @@@patients@@@ with mild structural @DISEASE_Heart_Diseases @DISEASE_MESH:D006331 @@@heart diseases@@@; the terminating effectiveness of propanorm was 79% during hospital treatment and 88% in outpatients in the selected group of @SPECIES_9606 @@@patients@@@ without a significant number of side effects. Treatment with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (dapril) was followed by a decrease in the number of paroxysms, duration of @<m>DISEASE_Arrhythmias_Cardiac</m> @DISEASE_MESH:D001145 @@@arrhythmia@@@ episodes, and a tendency to transformation into asymptomatic form. ", "citations": {"NLM": "Tatarskiĭ BA. [Alternative approaches to treatment of paroxysmal atrial fibrillation]. Vestn Ross Akad Med Nauk. 2007;(4):3-9. PMID: 17561641", "BibTeX": "@article{17561641, title={[Alternative approaches to treatment of paroxysmal atrial fibrillation].}, author={Tatarskiĭ BA}, journal={Vestn Ross Akad Med Nauk}, number={4}, pages={3-9}}"}}, {"_id": "26639710", "pmid": 26639710, "title": "Adherence to EBM guidelines in clinical practice.", "journal": "Int J Risk Saf Med", "authors": ["Khafizianova RKh", "Burykin IM"], "date": "2015-01-01T00:00:00Z", "doi": "10.3233/JRS-150687", "meta_date_publication": "2015", "meta_volume": "27 Suppl 1", "meta_issue": "", "meta_pages": "S53-4", "score": 50021.324, "text_hl": "In 2009 @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ use decreased to 30%, while prescribing of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ increased from 0 in 2006 to 13.3%. ", "citations": {"NLM": "Khafizianova RKh, Burykin IM. Adherence to EBM guidelines in clinical practice. Int J Risk Saf Med. 2015;27 Suppl 1():S53-4. PMID: 26639710", "BibTeX": "@article{26639710, title={Adherence to EBM guidelines in clinical practice.}, author={Khafizianova RKh and Burykin IM}, journal={Int J Risk Saf Med}, volume={27 Suppl 1}, pages={S53-4}}"}}]}